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Abstract
Background: The prevalence of comorbidity is high, with 80% of the elderly population having
three or more chronic conditions. Comorbidity is associated with a decline in many health
outcomes and increases in mortality and use of health care resources. The aim of this study was to
identify, review and summarise studies reporting the prevalence of comorbidity of chronic diseases
in Australia.
Methods: A systematic review of Australian studies (1996 – May 2007) was conducted. The
review focused specifically on the chronic diseases included as national health priorities; arthritis,
asthma, cancer, cardiovascular disease (CVD), diabetes mellitus and mental health problems.
Results: A total of twenty five studies met our inclusion criteria. Over half of the elderly patients
with arthritis also had hypertension, 20% had CVD, 14% diabetes and 12% mental health problem.
Over 60% of patients with asthma reported arthritis as a comorbidity, 20% also had CVD and 16%
diabetes. Of those with CVD, 60% also had arthritis, 20% diabetes and 10% had asthma or mental
health problems.
Conclusion:  There are comparatively few Australian studies that focused on comorbidity
associated with chronic disease. However, they do show high prevalence of comorbidity across
national health priority areas. This suggests integration and co-ordination of the national health
priority areas is critical. A greater awareness of the importance of managing a patients' overall
health status within the context of comorbidity is needed together with, increased research on
comorbidity to provide an appropriate scientific basis on which to build evidence based care
guidelines for these multimorbid patients.
Background
The proportion of Australians aged 65 years and over is
projected to increase from 2.6 million in 2004, to over 6.5
million by 2051, with the highest projected growth rate
for those aged 80 years or older [1]. This ageing Australian
population, with a concomitant rise in the number of
people living with chronic diseases, has major implica-
tions for both health care services and their associated
costs. Chronic diseases are the leading cause of illness and
disability in those aged 65 years and over [2] and in 2000–
01 accounted for nearly 70% of all health system expend-
iture in Australia (over $AU 35 billion) [3-5]. The World
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Health Organisation estimates that chronic disease
accounts for 60% of deaths worldwide and has given prec-
edence globally to the prevention and treatment of
chronic disease [6].
The co-existence of multiple chronic diseases is common
especially in the older population [7]. The 2004–2005
Australian National Health Survey (NHS) reported almost
all Australians aged 65 years or older have at least one
chronic condition, with 80% reported as having three or
more chronic conditions [2,5]. Similar burdens have been
reported in other countries, including the USA and Can-
ada [8,9]. The presence of multiple chronic diseases is
associated with a decline in many health outcomes,
including quality of life, mobility, functional ability, and
increases in hospitalisations, psychological distress, mor-
tality and the use of health care resources [8,10-12].
The study of multimorbidity that is, the presence of two or
more chronic diseases or conditions within one person is
relatively new worldwide [13] and a recent editorial high-
lights the importance and growing awareness of this
endemic health problem, particularly with regard to
focusing worldwide research efforts in this area [14].
When multimorbidity is studied in relation to a particular
disease or 'index' disease, the term co-morbidity should
be used [15,16].
As a result of multimorbidity, polypharmacy in the elderly
is common. In Australia, almost 88% of those aged 65
years and over use at least one prescription medication
[17] with reports of between 43–55% of elderly patients
taking 4 or more medications regularly [17,18]. With
increasing numbers of concurrent medications, the risk of
adverse drug events increases significantly. It has been
estimated that the likelihood of an older person having an
adverse drug event increases from 10% if one medication
is taken, to 75% if five or more medications are used [18].
The incidence of medication-related problems and
adverse outcomes is increasing, especially in the elderly
[19-21].
While clinical guidelines have been developed to help
health professionals with the choice of appropriate treat-
ments, their relevance to the care of those with multiple
chronic diseases, particularly the elderly, has recently been
questioned [22-24]. Current evidence-based guidelines
often recommend several medications in the treatment of
individual chronic diseases, resulting in potentially very
complex regimens in those with multiple morbidities.
Moreover the evidence is largely based on relatively short-
term randomised clinical trials of single conditions and
often exclude the elderly or those with multimorbidity
[25]. A detailed understanding of the prevalence of multi-
morbidity and the common comorbidities associated
with chronic diseases in Australia may help to highlight
the complex issues surrounding the management of these
patients.
The aim of this study was to identify, review and summa-
rise studies describing the prevalence of multimorbidity
and comorbidity of chronic diseases in Australia over the
last decade. With a focus specifically on the chronic dis-
eases defined as Australian National Health Priority Areas
(NHPA), which include arthritis, asthma, cancer, cardio-
vascular disease (CVD), diabetes, and mental health prob-
lems (particularly depression) [26]. These NHPA account
for at least 60% of the total burden of disease and injury
and approximately $20 billion or 42% of allocated health
system expenditure in Australia [27].
Methods
Search Strategy
A systematic search of Medline (via Ovid) was conducted
for eligible articles published between January 1996 –
May 2007, inclusive. Searches were performed using
MeSH subject headings where relevant. The primary
search terms included "multimorbidity", "comorbidity",
"polymorbidity", "chronic condition", "chronic disease"
coupled with "Australia" or each of the states and capital
cities, to limit the search to work undertaken in Australia.
The search strategy also included the six chronic diseases
of interest "arthritis", "asthma" (and "chronic obstructive
pulmonary disorder" (COPD)), "cancer", "cardiovascular
diseases" (including ischemic heart disease, coronary
heart disease, hypertension, heart failure, coronary syn-
drome, cerebrovascular disease), "diabetes mellitus", and
"mental disorders" (including depression, affective disor-
ders, anxiety) together with the primary search terms or in
combination with one another and limited to Australian
studies.
In addition, websites of The Australian Institute of Health
and Welfare (AIHW), Commonwealth and all state gov-
ernment departments (e.g. The Department of Health)
and the Australian Bureau of Statistics (ABS) were
searched to locate relevant publication and reports. Refer-
ence lists of included studies were also searched to iden-
tify additional sources of information.
Inclusion/Exclusion Criteria
Only Australian studies where the prevalence of multi-
morbidity or comorbidities associated with the chronic
conditions detailed above were reported were included.
Articles were excluded if the search terms were only men-
tioned once in the introduction or discussion of the arti-
cle. The recent National Health Survey (NHS) 2004–05
was included and results from previous NHS were
excluded. The NHPA of mental health, focuses specifically
on depression, and the broad classification of affectiveBMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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disorders were included in this study. Substance abuse
disorders were excluded. Studies that reported depression
or anxiety at the time of hospitalisation for an acute CVD
episode were excluded. Studies scoring < 4 using the criti-
cal appraisal tool (see below) were deemed to be of low
quality and as such were excluded from the review.
Methodological Appraisal
An assessment of methodological rigour was conducted
using the critical appraisal guidelines for research articles
reporting prevalence, developed by Loney et al [28]. The
scoring system consisted of 8 dichotomous questions,
with 1 for yes and 0 for no, on the validity of the study
design (appropriate sampling methods and frame, ade-
quate sample size, appropriate outcomes measurements
and response rates), interpretation (prevalence given with
confidence intervals, adequate subgroup analysis) and
applicability of the results (study subjects and setting
described in detail). All questions were weighted equally
with higher scores reflecting better methodological qual-
ity of the studies.
Results
Study Characteristics
A summary of the results of the search is provided in Fig-
ure 1, which outlines the number of potentially relevant
studies initially identified and the loss to inclusion crite-
ria. Overall, a total of twenty five studies met our inclu-
sion criteria across the six chronic diseases of interest.
There were no Australian studies that reported the preva-
lence of multimorbidity. All of the 25 eligible studies
reported on the prevalence of co-morbidities of people
with an index chronic disease. The results were therefore
divided into each index chronic disease and then further
grouped according to the age of the studies participants.
These age groupings were divided into those studies that
looked specifically at elderly ( 65 years old, and the gen-
eral adult population, where applicable). In two instances
data from one study included both the elderly and the
adult populations [2,29].
The main findings from these studies including the study
population, type of data collected, prevalence of both the
index disease and co-morbidities and the critical appraisal
scores are summarised in Tables 1, 2, 3, 4, 5, 6. The
median quality score of the 25 studies included in this
review was 5 points out of a maximum score of 8 (range
4–7 points). The main areas of methodological shortcom-
ings of the reviewed studies included inadequate response
rates and descriptions of the non-responders (61.5% of
the studies) followed by 46%–58% of studies reporting
inappropriate sampling methods and biased sample
frames, respectively.
There were three types of data commonly used and
included self report, medical records and administrative
date, either exclusively or in combination. Eleven studies
used self-report of chronic conditions, either based on a
diagnosis by a medical practitioner [2,29-34] or general
subject self-report [2,35-39]. The NHS 2004–05 data was
based on self-report of medically diagnosed conditions,
except for mental health problems, that were participant
self-report and therefore may be based on self-diagnosis
[2]. Only two studies validated the self-report [33,38].
Twenty studies used medical records/clinical data. Medi-
cal records were used to identify patients diagnosed with
chronic disease either for the index disease itself [36,39-
41] and/or the co-morbidities [31-33,37,38,42-52]. Vali-
dated diagnostic questionnaires were used to diagnose
mental health disorders, specifically depression
[31,32,37,38,49,51] or anxiety [49,51].
Five studies used administrative records/data that were
based on hospital separations [40,41,44,46,52].
Co-morbidities of Chronic Disease
Arthritis
Four studies examined comorbidities in patients with
arthritis [2,29,35,42] (Table 1). Over half of the elderly
patients with arthritis had hypertension, followed by CVD
(20%), dyslipidemia (18.7%), diabetes (14%) and men-
tal health problem/depression (12%).
Summary of search results Figure 1
Summary of search results.
g
Full studies retrieved for more 
detailed evaluation (n=417) 
Potential relevant studies identified by 
electronic and manual searches: citations or 
abstracts screened for retrieval (n=9226) 
Selected studies included 
in review (n=25)
Studies excluded for not meeting 
inclusion criteria (n=391) or were 
low quality (score < 4 using critical 
appraisal tool) (n=1) BMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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Asthma
The 2004–5 NHS reported over 60% of elderly patients
with asthma reported arthritis as a comorbidity followed
by CVD (20.1%) and diabetes (16%) (Table 2) [2]. In
three studies of all adults with asthma, almost one third of
patients had arthritis [2,31,36]. Mental health was also
common, its prevalence ranged from 14–22% when
determined from self-report [2] or by questionnaire [31].
Hypertension affected almost 20% of patients, followed
by CVD (12%) in a study of GP recruited asthma patients
[36]. There were no studies that examined the prevalence
of comorbidity associated with COPD nor all respiratory
diseases.
Cancer
Over half of the patients with cancer from the 2004–5
NHS reported arthritis as a comorbidity followed by men-
tal health problems (16.1%), asthma (15.1%) and CVD
(14.6%) (Table 3)[2]. Arthritis was the most common
comorbidity of cancer patients across all ages (43.8%),
Table 1: Summary of studies reporting comorbidities with arthritis.
Comorbidity Study Study 
Quality 
Score/8
Asthma
(%)
CVD
(%)
Diabetes
(%)
Dyslipidemia
(%)
Hypertension
(%)
Malignancy
(%)
Mental 
problem/
depression#
(%)
Osteoporosis
(%)
Arthritis
Hill et al, 2006 [29] ≥ 
55 yrs n = 2,054 self-
report of doctor 
diagnosed arthritis 
(prevalence 43.9%) 
and mental health 
condition
6- - - - - - 1 3 . 1 -
NHS 2004–05 [2] ≥ 
65 yrs n = 3,212 self-
report of all 
conditions (prevalence 
arthritis 49.4%)
7 12.1 21.5 14.1 - - 6.9 8.8 -
O'Halloran et al, 2003 
[42] ≥ 65 yrs n = 
2,976 GP encounters 
(OAa prevalence 
20.9%)
5- 1 8 . 7  ( I H D a) 13.9 18.7 50.8 - 12.9# 11.5
Hill et al, 2006 [29] ≥ 
18 yrs n = 7,473 self-
report of doctor 
diagnosed arthritis 
(prevalence 18.3%) 
and mental health 
condition
6- - - - - - 1 4 . 9 -
NHS 2004–05 [2] ≥ 
25 yrs n = 17,202 self-
report of all 
conditions (prevalence 
of arthritis 22.8%)
7 13.2 12.7b 9.3b -- 5 . 0 1 3 . 3 -
Waghorn et al, 2006 
[35] 15–64 yrs n = 
37,580 self-report 
1998 SDACc 
(prevalence arthritis 
9.2%)
5- - - - - - 6 . 0 d -
-, not reported; #, depression only;a OA, osteoarthritis; IHD, ischaemic heart disease; b ≥ 45 years, data for 25 years and over were reported to 
have a high standard error and were deemed to be used with caution2; c SDAC; ABS Survey of Disability, Ageing and Carers; d depression and 
anxiety.BMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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followed CVD (18.3%) [2] and the broad classification of
respiratory diseases (12%) [52].
Diabetes
In accordance with the documented association of diabe-
tes with CVD and its associated risk factors including
hypertension and dyslipidemia [53], these were promi-
nent co-morbidities of diabetic elderly patients (Table 4)
[2,42,43].
Arthritis was present in over half of those with diabetes
from the 2004–05 NHS [2], and in 20% of diabetic
patients presenting to their GP [42] and depression was
present in approximately 10% of elderly patients with dia-
betes [42].
When extended to the adult population with diabetes,
similar associations of CVD, hypertension and dyslipi-
demia as common comorbidities were observed [2,32-
34,38,40]. Hypertension was the most prevalent comor-
bidity (51–58%) whether determined from clinical exam-
ination, self-report or hypertension medications
[33,34,38]. Prevalence rates of CVD were approximately
40–55% in two studies of self-report [34,38] but only
12% from hospital administrative data [40] in diabetic
patients. Arthritis was reported by almost half of the dia-
Table 2: Summary of studies reporting comorbidities with asthma.
Comorbidity Study Study Quality 
Score/8
Arthritis
(%)
CVD
(%)
Diabetes
(%)
Hypertension
(%)
Malignancy
(%)
Mental problem/
depression#
(%)
Osteoporosis
(%)
Asthma
Adams et al, 2006 [30] ≥ 
55 yrs n = 2050 self-report 
of doctor diagnosed 
asthma and comorbidities 
(asthma prevalence 9.6%)
6 56.9 26.9 (HD)a
9.1 (Stroke)b
12.1 - 17.7 - 17.3
NHS 2004–05 [2] ≥ 65 yrs 
n = 3,212 self-report all 
conditions (asthma 
prevalence 9.41%)
7 63.4 20.1 16.0 - 5.7 8.1 -
Adams et al, 2006 [30] ≥ 
18 yrs n = 7,443 self-
report of doctor 
diagnosed asthma and 
comorbidities (asthma 
prevalence 11.2%)
6 21.4. 6.9 (HD)a
1.5 (Stroke)b
5.3 - 5.5 - 4.7
Goldney et al, 2003 [31] ≥ 
15 yrs (mean age 44 yrs) n 
= 3010 self-report of 
doctor diagnosed asthma 
(prevalence 9.9%), 
depression assessed by 
PRIME-MD questionnairec
6 - - - - - 22.1# (all 
depression)
14.4# (major 
depression)
-
NHS 2004–05 [2] ≥ 25 yrs 
n = 17,202 self-report all 
conditions (asthma 
prevalence 9.40%)
73 2 . 0 6 . 7 d 6.1d -3 . 2 d 15.0 -
Pilotto et al, 2004 [36] ≥ 
18 yrs (mean age 48 yrs) n 
= 170 GP recruitment of 
asthma patients, self-
report of comorbidities
4- 1 1 . 8 e 7.1 18.2 - - 6.5
-, not reported; #, depression only; aHD, Heart Disease; bStroke; cPRIME-MD, primary care evaluation of mental disorders questionnaire, a 
validated tool used to diagnose depression/mental health disorders; d ≥ 45 years, data for 25 years and over were reported to have a high standard 
error and were deemed to be used with caution2; eangina, heart failure or other heart disease.BMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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betics [2] and the prevalence of depression was 24%–32%
[32,38].
Cardiovascular Disease
Cardiovascular disease (CVD) encompasses a wide range
of disorders and Table 5 is further sub-divided into all
CVD; acute myocardial infarction (AMI) or acute coronary
syndromes (ACS) or ischaemic heart disease (IHD);
chronic heart failure (CHF); hypertension (HT); and
stroke. The reporting of comorbidities were similar, irre-
spective of the type of data used and age of the subjects
(Table 5). HT was a key comorbidity for half those with
CVD. Specific CVD states different from the 'index' CVD
condition were common co-morbidities. For example in
patients with MI, CHF was a co-existent CVD in almost a
quarter [44]. Dyslipidemia and diabetes were also promi-
nent comorbidities, present in 20% of those with CVD
and approximately 20 – 55% of patients with CVD had
arthritis [2,37,41,42,44-47].
Mental health problems
CVD, hypertension and dyslipidemia affected approxi-
mately 25%, 40% and 20% of older patients, respectively
with mental health problems. Arthritis was also reported
by 30% of patients [2,42]. When expanded to the adult
population, depression and anxiety were prevalent
comorbidities, as determined by diagnostic interviews for
mental health [49,51]. From the 2004–05 NHS, arthritis
was the most common comorbidity (30%), followed by
asthma (14.1%) and CVD (14%) in subjects with mental
health problems.
Discussion
The major impact of chronic diseases, with regard to their
large disease burden and associated costs, has placed them
at the fore of international and Australian strategic health
priorities [6,26]. Integral to this is the increasing number
of patients with multimorbidity of chronic conditions.
Despite the high prevalence of multimorbidity, particu-
larly in the elderly, there are comparatively few Australian
studies that focus on multimorbidity or comorbidities
associated with chronic disease. What this review shows,
however, is that there is much cross over of diseases that
are considered national health priority diseases for Aus-
tralia. For more than one in ten people and often more
than one in five, arthritis is found to be co-existent with
either CVD, diabetes, and mental health problems.
Asthma is also commonly co-existent with heart disease
and diabetes. This suggests integration and co-ordination
of Australia's national health priority areas will be critical
for improving health within each priority area.
Primary care physicians are the major providers of care for
patients with multimorbidity [54]. Arthritis, HT, CVD and
Table 3: Summary of studies reporting comorbidities with cancer.
Comorbidity Study Study Quality Score/8 Arthritis
(%)
Asthma
(%)
CVD
(%)
Diabetes
(%)
Hypertension
(%)
Mental health 
problem
(%)
Cancer
NHS 2004–05 [2] ≥ 65 
yrs n = 3,212 self-
report all conditions 
(malignant neoplasm 
prevalence 6.1%)
7 55.7 15.1 14.6 9.0 - 16.1
NHS 2004–05 [2] ≥ 25 
yrs n = 17,202 self-
report all conditions 
(malignant neoplasm 
prevalence 1.7%)
7 43.8 6.1 18.3 8.8 - 7.1
Valery et al, 2006 [52] 
all ages (85% ≥ 40 yrs) 
n = 810, non-
indigenous patients 
identified from cancer 
registry, comorbidities 
hospital administrative 
data and medical 
records
5 - 12.0 (Respiratory 
Disease)
5.0 (ACS)a 6.0 8.0 -
-, not reported; a ACS; Acute Coronary SyndromeBMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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Table 4: Summary of studies reporting comorbidities with diabetes.
Comorbidity Study Study 
Quality 
Score/8
Arthritis
(%)
Asthma
(%)
CVD
(%)
Dyslipidemia
(%)
Hypertension
(%)
Malignancy
(%)
Mental 
problem/
depression#
(%)
Osteoporosis
(%)
Diabetes
O'Halloran et al, 2003 
[42] ≥ 65 yrs n = 2,976 
GP encounters 
(diabetes prevalence 
14.4%)
52 0 . 1
(OA)a
-2 3 . 6
(IHD)a
22.2 52.7 - 9.0# 13.8
NHS 2004–05 [2] ≥ 65 
yrs n = 3,212 self-
report all conditions 
(diabetes prevalence 
13.7%)
7 51.0 11.0 26.7 - - 5.4 7.2
Thomas and Nestel, 
2007 [43] mean age = 
65 yrs, n = 3893 
NEFRON study, GP 
diagnosed type 2 
diabetes and 
comorbidities
4- - 4 0 . 1 b -- - - -
Bruce et al, 2005 ≥ 40 
yrs [38] (mean age 64 
yrs) n = 1,273 clinically 
diagnosed type 2 
diabetes, depression 
GHSc questionnaire, 
comorbidities self-
report validated with 
hospital records
5- - 4 1 . 5 d - 51.1 - 31.5#
Clarke et al, 2006 [40] 
≥ 35 yrs (mean age 64 
yrs), n = 20,538, 
diabetes diagnosed by 
diabetes medication, 
HbA1c or hospital 
diagnosis (primary or 
secondary ICD-9 250), 
co-morbidities 
identified from 
hospital administrative 
data (ICD-9 CM)
64 . 0 a
(Musc. Dis)
2.9a
(Resp Dis)
12.3e -- 5 . 6 0 . 9
Goldney et al, 2004 
[32] ≥ 15 yrs n = 3,010 
self-report of doctor 
diagnosed diabetes 
(prevalence 5.2%), 
depression by PRIME-
MDf questionnaire.
5 23.6#BMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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diabetes account for over 55% of chronic conditions man-
aged by GPs in Australia for the elderly [42]. Based on the
results from this review, potentially for every elderly
patient presenting to their GP with a chronic disease, one
in two will also have arthritis or HT, and one in five will
have a type of CVD or diabetes. When placed in this con-
text, the need for a greater awareness from both the physi-
cian and patient of the importance of managing a
patients' overall health status within the context of multi-
ple disease states, rather than a single disease entity, is
highlighted. The majority of research on chronic disease is
based on single index disease states, which is clearly inap-
propriate for patients with multimorbidity. The number
of evidence based studies in treating patients with multi-
ple chronic diseases, severely limits the ability to translate
research findings into clinical practice for this population.
Patients with multimorbidity need coordinated and con-
tinuing care that takes into account patient preferences
and disease severity. Patients with chronic disease make
daily decisions about the management of their diseases
[55] and patient self-management is essential for effective
chronic illness care and improved patient outcomes
[55,56]. There is increasing evidence that patients, in par-
ticular the elderly, vary in the emphasis they place on cer-
tain aspects of their health care, including mortality,
quality of life, risk of adverse events and medication
adherence [57]. From a patient's viewpoint, the effective
management of symptomatic conditions may take prece-
dence over asymptomatic conditions, despite the fact that
treatment of this asymptomatic condition may result in
decreased mortality with time. For example, symptomatic
treatment of osteoarthritis with an NSAID may result in
the greatest impact on the patient's quality of life but
should it take priority over the management of their HT?
There is a clear need for integrated care for patients with
multimorbidity.
The benefits of disease-specific guidelines for the prescrib-
ing of medications are well recognised. However, the
inclusion of strategies to treat or even account for multi-
morbidity in evidence-based disease specific guidelines is
rarely evident [22-24], and provide physicians little guid-
ance about caring for such patients.
The NHS (2004–05) was an important source of data in
this review, based largely on self-report of a health profes-
sional diagnosis. However, the majority of studies that
met our inclusion criteria were from clinical research stud-
ies that concentrated on a single chronic disease where the
reporting of comorbid conditions was often a secondary
variable or outcome measure and not an objective of the
Kemp et al, 2005 [33] 
≥ 25 yrs, n = 11,247 
AusDiab survey, self-
report doctor 
diagnosed diabetes, 
confirmed with 
hypoglycemic drug use 
or glucose tolerance 
test (diabetes 
prevalence 3.9%), 
clinical measurement 
of comorbidities.
5 - - - 47.1 53.8 - - -
Mitchell et al, 1998 
[34] ≥ 49 yrs, n = 
3,654 self report of 
doctor diagnosed 
diabetes (prevalence 
5.9%) and 
comorbidities
6 - - 54.7 - 57.6 - - -
NHS 2004–05 [2] ≥ 25 
yrs n = 17,202 self-
report all conditions 
(diabetes prevalence 
5.2%)
74 5 . 4 g 12.3g 20.9 - - 4.8 9.0
-, not reported; #, depression; a (OA, osteoarthritis; IHD, ischemic heart disease; CHD, coronary heart disease; CV, cervebrovascular disease; PVD, 
peripheral vascular disease; Musc. Dis, Musculoskeletal disease (ICD 710–739); Resp. Dis, Respiratory Disorder (ICD 460–519));b (coronary heart 
disease, cerebrovascular disease and peripheral vascular disease); c General Health Status (GHS) questionnaire, those reported as having at least 2 
depressive symptoms were classed as having depression; d coronary heart disease and cerebrovascular disease; e angina, AMI and stroke; f PRIME-
MD; primary care evaluation of mental disorders questionnaire, a validated tool used to diagnoses depression/mental disorders; g ≥ 45 years, data 
for 25 years and over were reported to have a high standard error and were deemed to be used with caution2.
Table 4: Summary of studies reporting comorbidities with diabetes. (Continued)BMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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Table 5: Summary of studies reporting comorbidities with cardiovascular disease.
Comorbidity Study Study 
Quality 
Score/8
Arthritis
(%)
Asthma
(%)
CVD
(%)
Diabetes
(%)
Dyslipidemia
(%)
Hypertension
(%)
Malignancy
(%)
Mental 
problem/
depression#
(%)
Cardiovascular Disease
NHS 2004–05 [2] ≥ 65 yrs n 
= 3,212 HSVDa self-report 
all conditions (prevalence 
18.4%)
7 57.9 10.3 ￿ 19.8 - - 8.4 10.5
Krum et al, 2006 [44] mean 
age 64 yrs, n = 479, 
admission to hospital for 
MIa, comorbidities from 
hospital administrative data 
and records
4 - - 24.2 (CHFa) 21.6 52.9 53.4 - -
O'Halloran et al, 2003 [42] ≥ 
65 yrs n = 2,976 GP 
encounters (IHDa 
prevalence 16.9%)
5 23.1 (OA) - 20.1 23.1 47.3 - 9.5#
Parker et al, 2006 [37] mean 
age 63 yrs, n = 489 hospital 
admission for ACSa, 
depression assessed by 
CIDIb, comorbidities self-
report
5 34.6 (pMIa) 17.3 63.5 10.6
Simons et al, 2002 [45] ≥ 60 
yrs n = 2,217 (Dubbo study) 
hospital admission for MIa 
(prevalence 18.7%), 
comorbidities from medical 
history and clinical 
examination
6-- 3 6 . 0  ( p C S a) 16.0 26.9 62.0 -
Krum et al, 2001 [46], ≥ 60 
yrs, n = 22,060, GP diagnosis 
CHFa (prevalence 13.2%), 
comorbidities from hospital 
administrative data and 
records
5 - - 44.8 (angina)
29.7 (pMIa)
-- 6 8 . 3- -
Stewart et al, 2001 [41] ≥ 55 
yrs (mean age 76 yrs) n = 
200 hospital admission 
CHFa, comorbidities hospital 
discharge data
4 - 36.0 
(CADa)
78.0 (IHDa)
70.0 (pMI)
32.0 - 66.0 - -
O'Halloran et al, 2003 [42] ≥ 
65 yrs n = 2976 GP 
encounters (HTc prevalence 
45.6%)
5 23.3 (OA) - 17.5 (IHDa) 16.7 23.7 ￿ - 9.0#
Sturm et al, 2004 [47] mean 
age 71 yrs, n = 226 
(NEMESIS)a, stroke detected 
& diagnosed by medical 
practitioner, comorbidities 
by past medical history and/
or current presentation 
(diabetes or AFa)
5 - - 23.5 (AFa)
6.2 (PVDa) 
8.8 (pMIa)
19.1 - 58.9 - -
NHS 2004–05 [2] ≥ 25 yrs n 
= 17,202 HSVD self-report 
all conditions (prevalence 
5.7%)
75 4 . 4 d 12.6 ￿ 19.2 - - 7.0d 14.0dBMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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study. This review not only highlights the need for
increased research into the study of multimorbidity or
comorbidities of chronic diseases, but also the need for
such studies to be of greater methodological rigour, given
that almost a third of the studies included in this review
scored only 50% using the critical appraisal tool. A similar
disparity between the prevalence of multimorbidity in the
general population of Canada and the number of research
publications [13], was recently reported by Fortin and col-
leagues where the majority of studies focused on the epi-
demiology of multimorbidity or its effects on quality of
life and physical functioning [14,22].
Our study has several limitations. The first is the risk of
not finding all relevant Australian articles. We only used
Medline with Ovid as the search engine and the search of
other databases may have increased the likelihood of find-
ing any additional papers. However, we felt that the use of
all the key index chronic diseases as MeSH terms in addi-
tion to multimorbidity and comorbidity would have
helped to ensure the identification all relevant articles.
Furthermore, in accord with the number of chronic dis-
eases and the diversity of articles included in this review,
there was considerable disparity between studies in the
methodological approach (the types of data used) and the
classification of diseases and was reflected in the diversity
of scores from the critical appraisal tool. Whilst self-report
of medical conditions is an important tool in epidemiol-
ogy research, its reported accuracy when compared with
medical records, which are considered the 'gold-standard'
of clinical data collection, appears to be disease specific
and may be greatest for chronic disorders requiring ongo-
ing management [58,59]. This was also evident in our
study, where a general consensus of self-report with med-
ical records was observed. The prevalence of comorbidi-
ties from hospital administrative data were generally
lower when compared with other types of data, similar
trends have previously been reported [48,60]. The classifi-
cation of diseases was sometimes problematic particularly
for CVD that incorporates a number of specific disease
entities, such as IHD or CHF. These differences in data
types and classification of disorders, in combination with
a marked lack of studies, particularly for arthritis, asthma,
cancer and mental health problems, made direct compar-
isons between studies sometimes difficult. Nevertheless,
distinct patterns of comorbid conditions were evident,
particularly for the older population. Arthritis, HT, CVD
and diabetes were clearly the most prominent co-morbid-
ities reported in this review. Whilst a strong relation
between age and the prevalence of many chronic diseases
exists, it does not negate from the importance and conse-
quences of comorbidity.
Powell et al, 2001 [48], 20–
85 yrs (mean age 66 yrs) n = 
1765, hospital admission for 
HD (AMI, angina, IHD, 
CHF)c ICD-9 CM, 
comorbidities extracted 
from medical records and 
coded to corresponding 
ICD-9 CM diagnosis codes
4 2.2 (RAa)1 4 . 6  
(CALa)
12.7 (Arra)
11.5 (CVa) 
8.2 (PVDa)
18.4 22.8 47.7 3.3 -
Burvill et al, 1997 [39] all 
ages, n = 191 (Perth 
community stroke study), 
first ever stroke (physician 
diagnosis), self-report co-
morbidities at time of 
strokee
4 - - 18.0 (pMI)
31.0 
((angina)
12.0 - 62.0 - 8.2#e
-, not reported; a(HSVD, Heart, Stroke and Vascular Disease, includes ischaemic heart disease (IHD), cerebrovascular disease (CV), oedema and 
chronic heart failure (CHF) and diseases of the arteries, arterioles and capillaries), MI myocardial infarction, ACS acute coronary syndrome 
(includes MI or unstable angina), pMI previous MI, pCS prior coronary syndrome, CAD chronic airways disease, NEMESIS North East Melbourne 
Stroke Incidence Study, AF atrial fibrillation, PVD peripheral vascular disease, HD heart disease, RA rheumatoid arthritis, CAL chronic airway 
limitation (asthma, emphysema), Arr arrhythmia; b Current depression assessed by Composite International Diagnostic Interview (CIDI) used the 
DSM symptom and duration criteria that included at least two or more weeks of major depression and/or two or more years of dysthmia, hence 
excluded individuals that developed depression at or around the time of their ACS and admission; c HT; hypertension defined as systolic blood 
pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, or use of antihypertensive drugs; d ≥ 45 years, data for 25 years and over were 
reported to have a high standard error and were deemed to be used with caution2; e n = 208, for study cohort that includes those depressed (n = 
17) at time of stroke.
Table 5: Summary of studies reporting comorbidities with cardiovascular disease. (Continued)BMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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Key issues for future study of multimorbidity that are not
only pertinent to Australia, but world-wide, include the
need to further define the populations of patients with
multiple chronic diseases and their medication patterns.
What is appropriate prescribing for patients with multi-
morbidity and what overall benefit may be achieved with
complex regimens of medications? Reductions in mortal-
ity from heart disease in Australia have been achieved over
the past couple of decades, with a combination of knowl-
edge, prevention strategies and improvements in treat-
ment options. The same can be achieved for patients with
chronic disease and the ever growing population of
patients with multimorbidity.
Table 6: Summary of studies reporting comorbidities with mental health problem/depression.
Comorbidity Study Study Quality 
Score/8
Arthritis
(%)
Asthma
(%)
CVD
(%)
Diabetes
(%)
Hypertension
(%)
Dyslipidemia
(%)
Malignancy
(%)
Mental 
problem/
depression
(%)
Mental health problem/
depression
O'Halloran et al, 2003 
[42] ≥ 65 yrs n = 2,976, 
GP encounters 
(depression prevalence 
10%)
5 27.0 (OA) - 15.9 
(IHD)
12.9 40.9 18.9 23.7 ￿
NHS 2004–05 [2] ≥ 65 
yrs n = 3,212 mental 
health and behavioural 
problemsa, self-report all 
conditions (prevalence 
9.5%)
7 30.0 5.28 26.7 6.8 - - 6.3 ￿
Hunt et al 2004 [49] ≥ 
18 yrs n = 10,241, 
generalised anxiety 
disorder diagnosed by 
composite international 
diagnostic interview 
(CIDI) (prevalence 4.5%) 
depression CIDI
4 - - - - - - - 38.9 
(depression)
NHS 2004–05 [2] ≥ 25 
yrs n = 17,202 mental 
health and behavioural 
problemsa, self-report all 
conditions (prevalence 
12.1%)
7 30.3 14.1 14.0 4.7 - - 6.3 ￿
Wilson et al 2003 [50] ≥ 
15 yrs n = 382 GP 
diagnosed depression 
(Medic-GP database), 
comorbidities from 
medical records
5 - - - - - - - 8.9 (anxiety)
National Survey of 
Mental Health and 
Wellbeing, 1997 [51] ≥ 
18 yrs n = 10,641 mental 
health problem 
diagnosed by CIDI 
(prevalence 12.3%)
7
Affective disorder 
(prevalence 3.8%)
- - - - - - - 47.3 (anxiety)
Anxiety disorder 
(prevalence 5.5%)
- - - - - - - 24.5 (affective)
-, not reported; aMental and behavioural problems include alcohol and drug, affective, anxiety-related, psychological development, behavioural and 
emotional, organic mental problems and symptoms and signs involving cognition, perception, emotional state and behaviour.BMC Public Health 2008, 8:221 http://www.biomedcentral.com/1471-2458/8/221
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Conclusion
Despite the high reported prevalence of patients with
multiple morbidities, there are comparatively few Austral-
ian studies that focused on comorbidity associated with
chronic disease. These studies do however demonstrate
the high prevalence of comorbidity across national health
priority areas, highlighting the need for integration and
co-ordination of the national health priority areas. Clearly
there is a need for more studies on multimorbidity to pro-
vide a strong evidence base on which to develop appropri-
ate guidelines for the care and management of these
patients.
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